Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...

The right clothing can help you minimize atopic dermatitis flares. Learn about common clothing triggers, plus tips on ...

Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.

In a single-center retrospective observational study at the Bari Polyclinic, researchers analyzed 50 adults with non-segmental vitiligo affecting 0.5 to 10% of their body surface area, including the ...

BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...

For me, there are two main takeaways from the study. The first is that we still don't take CSU seriously enough. It is a ...

Astria Therapeutics, Inc. acquired by BioCryst for $13 per share, with the deal set to finalize in 1Q26. Click here to read ...

NORTHAMPTON, MA / ACCESS Newswire / October 15, 2025 / NCDs are the leading cause of death globally, representing a ...

Boehringer Ingelheim, which has so far inked at least five hefty partnerships—including its latest one with South Korea’s AimedBio for an antibody-drug conjugate therapy for cancer.

Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for patients with skin of color, notes Elain Siegfried, MD.

The annual summit has become a flagship platform for scientific dialogue and knowledge exchange, bringing together top ...